Photodynamic therapy: a new antimicrobial approach to infectious disease?

Michael Hamblin

Tayyaba Hasan

^{Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA.}

^{Department of Dermatology, Harvard Medical School, Boston, MA 02115, USA}

^{Corresponding author.}

Michael R. Hamblin: ude.dravrah.hgm.xileh@nilbmah

Abstract

Photodynamic therapy (PDT) employs a non-toxic dye, termed a photosensitizer (PS), and low intensity visible light which, in the presence of oxygen, combine to produce cytotoxic species. PDT has the advantage of dual selectivity, in that the PS can be targeted to its destination cell or tissue and, in addition, the illumination can be spatially directed to the lesion. PDT has previously been used to kill pathogenic microorganisms in vitro, but its use to treat infections in animal models or patients has not, as yet, been much developed. It is known that Gram-(−) bacteria are resistant to PDT with many commonly used PS that will readily lead to phototoxicity in Gram-(+) species, and that PS bearing a cationic charge or the use of agents that increase the permeability of the outer membrane will increase the efficacy of killing Gram-(−) organisms. All the available evidence suggests that multi-antibiotic resistant strains are as easily killed by PDT as naïve strains, and that bacteria will not readily develop resistance to PDT. Treatment of localized infections with PDT requires selectivity of the PS for microbes over host cells, delivery of the PS into the infected area and the ability to effectively illuminate the lesion. Recently, there have been reports of PDT used to treat infections in selected animal models and some clinical trials: mainly for viral lesions, but also for acne, gastric infection by Helicobacter pylori and brain abcesses. Possible future clinical applications include infections in wounds and burns, rapidly spreading and intractable soft-tissue infections and abscesses, infections in body cavities such as the mouth, ear, nasal sinus, bladder and stomach, and surface infections of the cornea and skin.

Abstract

References

1. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng QPhotodynamic therapy. J. Natl. Cancer Inst. 1998;90:889–905.[Google Scholar]
2. Hamblin MR, Newman ELOn the mechanism of the tumour-localising effect in photodynamic therapy. J. Photochem. Photobiol., B. 1994;23:3–8.[PubMed][Google Scholar]
3. Ochsner MPhotophysical and photobiological processes in the photodynamic therapy of tumours. J. Photochem. Photobiol., B. 1997;39:1–18.[PubMed][Google Scholar]
4. Athar M, Mukhtar H, Bickers DRDifferential role of reactive oxygen intermediates in photofrin-I- and photofrin-II-mediated photoenhancement of lipid peroxidation in epidermal microsomal membranes. J. Invest. Dermatol. 1988;90:652–657.[PubMed][Google Scholar]
5. Redmond RW, Gamlin JNA compilation of singlet oxygen yields from biologically relevant molecules. Photochem. Photobiol. 1999;70:391–475.[PubMed][Google Scholar]
6. Bressler NM, Bressler SBPhotodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences. Invest. Ophthalmol. Vis. Sci. 2000;41:624–628.[PubMed][Google Scholar]
7. Boehncke WH, Elshorst-Schmidt T, Kaufmann RSystemic photodynamic therapy is a safe and effective treatment for psoriasis. Arch. Dermatol. 2000;136:271–272.[PubMed][Google Scholar]
8. Trauner KB, Hasan TPhotodynamic treatment of rheumatoid and inflammatory arthritis. Photochem. Photobiol. 1996;64:740–750.[PubMed][Google Scholar]
9. Barr HBarrett’s esophagus: treatment with 5-aminolevulinic acid photodynamic therapy. Gastrointest. Endosc. Clin. North Am. 2000;10:421–437.[PubMed][Google Scholar]
10. Rockson SG, Lorenz DP, Cheong WF, Woodburn KWPhotoangioplasty: an emerging clinical cardiovascular role for photodynamic therapy. Circulation. 2000;102:591–596.[PubMed][Google Scholar]
11. Jenkins MP, Buonaccorsi GA, Raphael M, Nyamekye I, McEwan JR, Bown SG, Bishop CCClinical study of adjuvant photodynamic therapy to reduce restenosis following femoral angioplasty. Br. J. Surg. 1999;86:1258–1263.[PubMed][Google Scholar]
12. Schafer M, Schmitz C, Facius R, Horneck G, Milow B, Funken KH, Ortner JSystematic study of parameters influencing the action of Rose Bengal with visible light on bacterial cells: comparison between the biological effect and singlet-oxygen production. Photochem. Photobiol. 2000;71:514–523.[PubMed][Google Scholar]
13. Bhatti M, MacRobert A, Meghji S, Henderson B, Wilson MA study of the uptake of toluidine blue O by Porphyromonas gingivalis and the mechanism of lethal photosensitization. Photochem. Photobiol. 1998;68:370–376.[PubMed][Google Scholar]
14. Hass BS, Webb RB. Photodynamic effects of dyes on bacteria. IV. Lethal effects of acridine orange and 460- or 500-nm monochromatic light in strains of Escherichia coli that differ in repair capability. Mutat. Res. 1981;81:277–285.[PubMed]
15. Kubin A, Wierrani F, Jindra RH, Loew HG, Grunberger W, Ebermann R, Alth GAntagonistic effects of combination photosensitization by hypericin, meso-tetrahydroxyphenylchlorin (mTHPC) and photofrin II on Staphylococcus aureus. Drugs Exp. Clin. Res. 1999;25:13–21.[PubMed][Google Scholar]
16. Yoshikawa TTAntimicrobial resistance and aging: beginning of the end of the antibiotic era? J. Am. Geriatr. Soc. 2002;50:S226–S229.[PubMed][Google Scholar]
17. Cunha BA. Antibiotic resistance. Control strategies. Crit. Care Clin. 1998;14:309–327.[PubMed]
18. Cassell GH, Mekalanos JDevelopment of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance. JAMA, J. Am. Med. Assoc. 2001;285:601–605.[PubMed][Google Scholar]
19. Cerveny KE, DePaola A, Duckworth DH, Gulig PAPhage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice. Infect. Immun. 2002;70:6251–6262.[Google Scholar]
20. Sajjan US, Tran LT, Sole N, Rovaldi C, Akiyama A, Friden PM, Forstner JF, Rothstein DMP-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients. Antimicrob. Agents Chemother. 2001;45:3437–3444.[Google Scholar]
21. Wainwright MPhotodynamic antimicrobial chemotherapy (PACT) J. Antimicrob. Chemother. 1998;42:13–28.[PubMed][Google Scholar]
22. Wainwright M, Phoenix DA, Laycock SL, Wareing DR, Wright PAPhotobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol. Lett. 1998;160:177–181.[PubMed][Google Scholar]
23. Wilson M, Yianni CKilling of methicillin-resistant Staphylococcus aureus by low-power laser light. J. Med. Microbiol. 1995;42:62–66.[PubMed][Google Scholar]
24. Raab CBer die wirkung fluoreszierender stoffe auf infusoria. Z. Biol. 1900;39:524–546.[PubMed][Google Scholar]
25. Jesionek A, von Tappeiner HZur behandlung der hautcarcinomit mit fluorescierenden stoffen. Muench. Med. Wochenschr. 1903;47:2042–2044.[PubMed][Google Scholar]
26. Hausmann WDie sensibilisierende wirkung tierscher farbstoffe und ihne physiologische bedeutung. Wien. Klin. Wochenschr. 1908;21:1527–1529.[PubMed][Google Scholar]
27. Benov L, Batinic-Haberle I, Spasojevic I, Fridovich IIsomeric N-alkylpyridylporphyrins and their Zn(II) complexes: inactive as SOD mimics but powerful photosensitizers. Arch. Biochem. Biophys. 2002;402:159–165.[PubMed][Google Scholar]
28. Nitzan Y, Ashkenazi HPhotoinactivation of Acinetobacter baumannii and Escherichia coli B by a cationic hydrophilic porphyrin at various light wavelengths. Curr. Microbiol. 2001;42:408–414.[PubMed][Google Scholar]
29. Zeina B, Greenman J, Purcell WM, Das BKilling of cutaneous microbial species by photodynamic therapy. Br. J. Dermatol. 2001;144:274–278.[PubMed][Google Scholar]
30. Tolstykh PI, Stranadko EF, Koraboev UM, Urinov A, Tolstykh MP, Terekhova RP, Volkova NN, Duvanskii VAExperimental study of photodynamic effect on bacterial wound microflora. Zh. Mikrobiol. Epidemiol. Immunobiol. 2001:85–87.[PubMed][Google Scholar]
31. Usacheva MN, Teichert MC, Biel MAComparison of the methylene blue and toluidine blue photobactericidal efficacy against gram-positive and gram-negative microorganisms. Lasers Surg. Med. 2001;29:165–173.[PubMed][Google Scholar]
32. Gabor F, Szocs K, Maillard P, Csik GPhotobiological activity of exogenous and endogenous porphyrin derivatives in Escherichia coli and Enterococcus hirae cells. Radiat. Environ. Biophys. 2001;40:145–151.[PubMed][Google Scholar]
33. Bertoloni G, Lauro FM, Cortella G, Merchat MPhotosensitizing activity of hematoporphyrin on Staphylococcus aureus cells. Biochim. Biophys. Acta. 2000;1475:169–174.[PubMed][Google Scholar]
34. Szocs K, Gabor F, Csik G, Fidy Jdelta-Aminolaevulinic acid-induced porphyrin synthesis and photodynamic inactivation of Escherichia coli B. J. Photochem. Photobiol., B. 1999;50:8–17.[PubMed][Google Scholar]
35. Golding PS, King TA, Maddocks L, Drucker DB, Blinkhorn ASPhotosensitization of Staphylococcus aureus with malachite green isothiocyanate: inactivation efficiency and spectroscopic analysis. J. Photochem. Photobiol., B. 1998;47:202–210.[PubMed][Google Scholar]
36. van der Meulen FW, Ibrahim K, Sterenborg HJ, Alphen LV, Maikoe A, Dankert JPhotodynamic destruction of Haemophilus parainfluenzae by endogenously produced porphyrins. J. Photochem. Photobiol., B. 1997;40:204–208.[PubMed][Google Scholar]
37. Minnock A, Vernon DI, Schofield J, Griffiths J, Parish JH, Brown SB. Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both gram-negative and gram-positive bacteria. J. Photochem. Photobiol., B. 1996;32:159–164.[PubMed]
38. Nitzan Y, Dror R, Ladan H, Malik Z, Kimel S, Gottfried VStructure-activity relationship of porphines for photoinactivation of bacteria. Photochem. Photobiol. 1995;62:342–347.[PubMed][Google Scholar]
39. Shawar R, Cooper BHComparative kinetics of hematoporphyrin derivative uptake and susceptibility of Bacillus subtilis and Streptococcus faecalis to photodynamic action. Photochem. Photobiol. 1990;52:825–830.[PubMed][Google Scholar]
40. Bedwell J, Holton J, Vaira D, MacRobert AJ, Bown SGIn vitro killing of Helicobacter pylori with photodynamic therapy. Lancet. 1990;335:1287.[PubMed][Google Scholar]
41. Dahl TA, Midden WR, Neckers DCComparison of photodynamic action by Rose Bengal in gram-positive and gram-negative bacteria. Photochem. Photobiol. 1988;48:607–612.[PubMed][Google Scholar]
42. Martin JP, Logsdon NThe role of oxygen radicals in dye-mediated photodynamic effects in Escherichia coli B. J. Biol. Chem. 1987;262:7213–7219.[PubMed][Google Scholar]
43. Banks JG, Board RG, Carter J, Dodge ADThe cytotoxic and photodynamic inactivation of micro-organisms by Rose Bengal. J. Appl. Bacteriol. 1985;58:391–400.[PubMed][Google Scholar]
44. Malik Z, Ladan H, Nitzan YPhotodynamic inactivation of Gram-negative bacteria: problems and possible solutions. J. Photochem. Photobiol., B. 1992;14:262–266.[PubMed][Google Scholar]
45. Nitzan Y, Gutterman M, Malik Z, Ehrenberg BInactivation of gram-negative bacteria by photosensitized porphyrins. Photochem. Photobiol. 1992;55:89–96.[PubMed][Google Scholar]
46. Nitzan Y, Balzam-Sudakevitz A, Ashkenazi HEradication of Acinetobacter baumannii by photosensitized agents in vitro. J. Photochem. Photobiol., B. 1998;42:211–218.[PubMed][Google Scholar]
47. Malik Z, Ladan H, Nitzan Y, Ehrenberg B. The bactericidal activity of a deuteroporphyrin-hemin mixture on gram-positive bacteria. A microbiological and spectroscopic study. J. Photochem. Photobiol., B. 1990;6:419–430.[PubMed]
48. Bertoloni G, Rossi F, Valduga G, Jori G, van Lier JPhotosensitizing activity of water- and lipid-soluble phthalocyanines on Escherichia coli. FEMS Microbiol. Lett. 1990;59:149–155.[PubMed][Google Scholar]
49. Wilson MPhotolysis of oral bacteria and its potential use in the treatment of caries and periodontal disease. J. Appl. Bacteriol. 1993;75:299–306.[PubMed][Google Scholar]
50. Wilson M, Dobson J, Harvey WSensitisation of oral bacteria to killing by low-power laser irradiation. Curr. Microbiol. 1992;25:77–81.[PubMed][Google Scholar]
51. Millson CE, Wilson M, Macrobert AJ, Bedwell J, Bown SGThe killing of Helicobacter pylori by low-power laser light in the presence of a photosensitiser. J. Med. Microbiol. 1996;44:245–252.[PubMed][Google Scholar]
52. Wilson M, Pratten JLethal photosensitisation of Staphylococcus aureus in vitro: effect of growth phase, serum, and pre-irradiation time. Lasers Surg. Med. 1995;16:272–276.[PubMed][Google Scholar]
53. Merchat M, Bertolini G, Giacomini P, Villanueva A, Jori GMeso-substituted cationic porphyrins as efficient photosensitizers of gram-positive and gram-negative bacteria. J. Photochem., Photobiol. B. 1996;32:153–157.[PubMed][Google Scholar]
54. Minnock A, Vernon DI, Schofield J, Griffiths J, Parish JH, Brown SBMechanism of uptake of a cationic water-soluble pyridinium zinc phthalocyanine across the outer membrane of Escherichia coli. Antimicrob. Agents Chemother. 2000;44:522–527.[Google Scholar]
55. Dahl TA, Midden WR, Hartman PEPure singlet oxygen cytotoxicity for bacteria. Photochem. Photobiol. 1987;46:345–352.[PubMed][Google Scholar]
56. Dahl TA, Midden WR, Hartman PEComparison of killing of gram-negative and gram-positive bacteria by pure singlet oxygen. J. Bacteriol. 1989;171:2188–2194.[Google Scholar]
57. Bezman SA, Burtis PA, Izod TP, Thayer MA. Photodynamic inactivation of E. coli by rose bengal immobilized on polystyrene beads. Photochem. Photobiol. 1978;28:325–329.[PubMed]
58. Friedberg JS, Tompkins RG, Rakestraw SL, Warren SW, Fischman AJ, Yarmush ML. Antibody-targeted photolysis. Bacteriocidal effects of Sn (IV) chlorin e6-dextran-monoclonal antibody conjugates. Ann. N. Y. Acad. Sci. 1991;618:383–393.[PubMed]
59. Strong L, Yarmush DM, Yarmush ML. Antibody-targeted photolysis. Photophysical, biochemical, and pharmacokinetic properties of antibacterial conjugates. Ann. N. Y. Acad. Sci. 1994;745:297–320.[PubMed]
60. Gross S, Brandis A, Chen L, Rosenbach-Belkin V, Roehrs S, Scherz A, Salomon YProtein-A-mediated targeting of bacteriochlorophyll-IgG to Staphylococcus aureus: a model for enhanced site-specific photocytotoxicity. Photochem. Photobiol. 1997;66:872–878.[PubMed][Google Scholar]
61. Fiel RJ, Datta-Gupta N, Mark EH, Howard JCInduction of DNA damage by porphyrin photosensitizers. Cancer Res. 1981;41:3543–3545.[PubMed][Google Scholar]
62. Menezes S, Capella MA, Caldas LRPhotodynamic action of methylene blue: repair and mutation in Escherichia coli. J. Photochem. Photobiol., B. 1990;5:505–517.[PubMed][Google Scholar]
63. Capella M, Coelho AM, Menezes SEffect of glucose on photodynamic action of methylene blue in Escherichia coli cells. Photochem. Photobiol. 1996;64:205–210.[PubMed][Google Scholar]
64. Hass BS, Webb RB. Photodynamic effects of dyes on bacteria. III. Mutagenesis by acridine orange and 500-nm monochromatic light in strains of Escherichia coli that differ in repair capability. Mutat. Res. 1979;60:1–11.[PubMed]
65. Imray FP, MacPhee DGThe role of DNA polymerase I and the rec system in survival of bacteria and bacteriophages damaged by the photodynamic action of acridine orange. Mol. Gen. Genet. 1973;123:289–298.[PubMed][Google Scholar]
66. Schafer M, Schmitz C, Horneck GHigh sensitivity of Deinococcus radiodurans to photodynamically-produced singlet oxygen. Int. J. Radiat. Biol. 1998;74:249–253.[PubMed][Google Scholar]
67. Valduga G, Breda B, Giacometti GM, Jori G, Reddi EPhotosensitization of wild and mutant strains of Escherichia coli by meso-tetra (N-methyl-4-pyridyl)porphine. Biochem. Biophys. Res. Commun. 1999;256:84–88.[PubMed][Google Scholar]
68. Konig K, Teschke M, Sigusch B, Glockmann E, Eick S, Pfister WRed light kills bacteria via photodynamic action. Cell. Mol. Biol. (Paris) 2000;46:1297–1303.[PubMed][Google Scholar]
69. Brazier JSA note on ultra-violet red fluorescence of anaerobic bacteria in vitro. J. Appl. Bacteriol. 1986;60:121–126.[PubMed][Google Scholar]
70. Brazier JSAnalysis of the porphyrin content of fluorescent pus by absorption spectrophotometry and high performance liquid chromatography. J. Med. Microbiol. 1990;33:29–34.[PubMed][Google Scholar]
71. Jousimies-Somer H, Summanen PRecent taxonomic changes and terminology update of clinically significant anaerobic gram-negative bacteria (excluding spirochetes) Clin. Infect. Dis. 2002;35:S17–S21.[PubMed][Google Scholar]
72. Okamoto K, Nakayama K, Kadowaki T, Abe N, Ratnayake DB, Yamamoto KInvolvement of a lysine-specific cysteine proteinase in hemoglobin adsorption and heme accumulation by Porphyromonas gingivalis. J. Biol. Chem. 1998;273:21 225–21 231.[PubMed][Google Scholar]
73. Shah HN, Gharbia SEBiochemical and chemical analyses of black-pigmented gram-negative anaerobes. FEMS Immunol. Med. Microbiol. 1993;6:89–96.[PubMed][Google Scholar]
74. Shah HN, Bonnett R, Mateen B, Williams RAThe porphyrin pigmentation of subspecies of Bacteroides melaninogenicus. Biochem. J. 1979;180:45–50.[Google Scholar]
75. Henry CA, Judy M, Dyer B, Wagner M, Matthews JLSensitivity of Porphyromonas and Prevotella species in liquid media to argon laser. Photochem. Photobiol. 1995;61:410–413.[PubMed][Google Scholar]
76. O’Brian MR, Thony-Meyer LBiochemistry, regulation and genomics of haem biosynthesis in prokaryotes. Adv. Microb. Physiol. 2002;46:257–318.[PubMed][Google Scholar]
77. Johnsson A, Kjeldstad B, Melo TBFluorescence from pilosebaceous follicles. Arch. Dermatol. Res. 1987;279:190–193.[PubMed][Google Scholar]
78. Lucchina LC, Kollias N, Gillies R, Phillips SB, Muccini JA, Stiller MJ, Trancik RJ, Drake LAFluorescence photography in the evaluation of acne. J. Am. Acad. Dermatol. 1996;35:58–63.[PubMed][Google Scholar]
79. Meffert H, Gaunitz K, Gutewort T, Amlong UJ. Therapy of acne with visible light. Decreased irradiation time by using a blue-light high-energy lamp. Dermatol. Monatsschr. 1990;176:597–603.[PubMed]
80. Melo TB, Johnsson M. In vivo porphyrin fluorescence for Propionibacterium acnes. A characterization of the fluorescing pigments. Dermatologica. 1982;164:167–174.[PubMed]
81. Hamblin MR, Ahmadi A, Tolkoff MJ, Zahra T. Light-mediated killing of Helicobacter pylori in vitro and ex vivo. 30th Annual Meeting of the American Society for Photobiology, Quebec City, Canada; American Society for Photobiology; Washington, DC. 2002. pp. 30–31. [PubMed]
82. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer. 1997;79:2282–2308.[PubMed]
83. Szocs K, Csik G, Kaposi AD, Fidy JIn situ detection of ALA-stimulated porphyrin metabolic products in Escherichia coli B by fluorescence line narrowing spectroscopy. Biochim. Biophys. Acta. 2001;1541:170–178.[PubMed][Google Scholar]
84. Strakhovskaya MG, Shumarina AO, Fraikin GY, Rubin ABSynthesis of protoporphyrin IX induced by 5-aminolevulinic acid in yeast cells in the presence of 2,2;-dipyridyl. Biokhimiya (Moscow) 1998;63:725–728.[PubMed][Google Scholar]
85. Strakhovskaya MG, Ivanova EV, Kolesnikova OA, Fraikin GYEffect of 2,2′-dipyridyl on accumulation of protoporphyrin IX and its derivatives in yeast mitochondria and plasma membranes. Biokhimiya (Moscow) 1999;64:213–216.[PubMed][Google Scholar]
86. Strakhovskaya MG, Shumarina AO, Fraikin G, Rubin ABEndogenous porphyrin accumulation and photosensitization in the yeast Saccharomyces cerevisiae in the presence of 2,2′-dipyridyl. J. Photochem. Photobiol., B. 1999;49:18–22.[PubMed][Google Scholar]
87. Soukos NS, Wilson M, Burns T, Speight PMPhotodynamic effects of toluidine blue on human oral keratinocytes and fibroblasts and Streptococcus sanguis evaluated in vitro. Las. Surg. Med. 1996;18:253–259.[PubMed][Google Scholar]
88. Soncin M, Fabris C, Busetti A, Dei D, Nistri D, Roncucci G, Jori GApproaches to selectivity in the Zn(II)–phthalocyanine photosensitized inactivation of wild-type and antibiotic-resistant Staphylococcus aureus. Photochem. Photobiol. Sci. 2002;1:815–819.[PubMed][Google Scholar]
89. deHaseth PL, Zupancic ML, Record MT., Jr RNA polymerase-promoter interactions: the comings and goings of RNA polymerase. J. Bacteriol. 1998;180:3019–3025.
90. Callaci S, Heyduk E, Heyduk T. Core RNA polymerase from E. coli induces a major change in the domain arrangement of the sigma 70 subunit. Mol. Cell. 1999;3:229–238.[PubMed]
91. Hengge-Aronis R, Lange R, Henneberg N, Fischer DOsmotic regulation of rpoS-dependent genes in Escherichia coli. J. Bacteriol. 1993;175:259–265.[Google Scholar]
92. Zgurskaya HI, Keyhan M, Matin AThe sigma S level in starving Escherichia coli cells increases solely as a result of its increased stability, despite decreased synthesis. Mol. Microbiol. 1997;24:643–651.[PubMed][Google Scholar]
93. Parsek MR, Val DL, Hanzelka BL, Cronan JE, Jr, Greenberg EPAcyl homoserine-lactone quorum-sensing signal generation. Proc. Natl. Acad. Sci. U. S. A. 1999;96:4360–4365.[Google Scholar]
94. Cabiscol E, Tamarit J, Ros JOxidative stress in bacteria and protein damage by reactive oxygen species. Int. Microbiol. 2000;3:3–8.[PubMed][Google Scholar]
95. Pomposiello PJ, Demple BRedox-operated genetic switches: the SoxR and OxyR transcription factors. Trends Biotechnol. 2001;19:109–114.[PubMed][Google Scholar]
96. Leive LThe barrier function of the gram-negative envelope. Ann. N. Y. Acad. Sci. 1974;235:109–129.[PubMed][Google Scholar]
97. Leive L, Kollin VControlling EDTA treatment to produce permeable Escherichia coli with normal metabolic processes. Biochem. Biophys. Res. Commun. 1967;28:229–236.[PubMed][Google Scholar]
98. Boman HGPeptide antibiotics: holy or heretic grails of innate immunity? Scand. J. Immunol. 1996;43:475–482.[PubMed][Google Scholar]
99. Hancock RE, Bell AAntibiotic uptake into gram-negative bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 1988;7:713–720.[PubMed][Google Scholar]
100. Christensen B, Fink J, Merrifield RB, Mauzerall DChannel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes. Proc. Natl. Acad. Sci. U. S. A. 1988;85:5072–5076.[Google Scholar]
101. Vaara M, Vaara TPolycations as outer membrane-disorganizing agents. Antimicrob. Agents Chemother. 1983;24:114–122.[Google Scholar]
102. Vaara M, Vaara TPolycations sensitize enteric bacteria to antibiotics. Antimicrob. Agents Chemother. 1983;24:107–113.[Google Scholar]
103. Helander IM, Alakomi HL, Latva-Kala K, Koski PPolyethyleneimine is an effective permeabilizer of gram-negative bacteria. Microbiology. 1997;143:3193–3199.[PubMed][Google Scholar]
104. Hancock RE, Wong PGCompounds which increase the permeability of the Pseudomonas aeruginosa outer membrane. Antimicrob. Agents Chemother. 1984;26:48–52.[Google Scholar]
105. Soukos NS, Hamblin MR, Hasan TThe effect of charge on cellular uptake and phototoxicity of polylysine chlorin e6 conjugates. Photochem. Photobiol. 1997;65:723–729.[PubMed][Google Scholar]
106. Rovaldi CR, Pievsky A, Sole NA, Friden PM, Rothstein DM, Spacciapoli PPhotoactive porphyrin derivative with broad-spectrum activity against oral pathogens in vitro. Antimicrob. Agents Chemother. 2000;44:3364–3367.[Google Scholar]
107. Polo L, Segalla A, Bertoloni G, Jori G, Schaffner K, Reddi EPolylysine-porphycene conjugates as efficient photosensitizers for the inactivation of microbial pathogens. J. Photochem. Photobiol., B. 2000;59:152–158.[PubMed][Google Scholar]
108. Lauro F, Pretto P, Covolo L, Jori G, Bertoloni GPhotoinactivation of bacterial strains involved in periodontal diseases sensitized by porphycene-polylysine conjugates. Photochem. Photobiol. Sci. 2002;1:468–470.[PubMed][Google Scholar]
109. Hamblin MR, O’Donnell DA, Murthy N, Rajagopalan K, Michaud N, Sherwood ME, Hasan TPolycationic photosensitizer conjugates: effects of chain length and Gram classification on the photodynamic inactivation of bacteria. J. Antimicrob. Chemother. 2002;49:941–951.[PubMed][Google Scholar]
110. Komerik N, Wilson M, Poole SThe effect of photodynamic action on two virulence factors of gram-negative bacteria. Photochem. Photobiol. 2000;72:676–680.[PubMed][Google Scholar]
111. Allen CM, Weber JM, van Lier JESulfophthalocyanines for photodynamic inactivation of viruses in blood products: effect of structural modifications. Photochem. Photobiol. 1995;62:184–189.[PubMed][Google Scholar]
112. Mohr H, Lambrecht B, Selz APhotodynamic virus inactivation of blood components. Immunol. Invest. 1995;24:73–85.[PubMed][Google Scholar]
113. Santus R, Grellier P, Schrevel J, Maziere JC, Stoltz JFPhotodecontamination of blood components: advantages and drawbacks. Clin. Hemorheol. Microcirc. 1998;18:299–308.[PubMed][Google Scholar]
114. Kasermann F, Kempf CPhotodynamic inactivation of enveloped viruses by buckminsterfullerene. Antiviral Res. 1997;34:65–70.[PubMed][Google Scholar]
115. Moor AC, Wagenaars-van Gompel AE, Brand A, Dubbelman MA, VanSteveninck JPrimary targets for photoinactivation of vesicular stomatitis virus by AIPcS4 or Pc4 and red light. Photochem. Photobiol. 1997;65:465–470.[PubMed][Google Scholar]
116. Bachmann B, Knuver-Hopf J, Lambrecht B, Mohr HTarget structures for HIV-1 inactivation by methylene blue and light. J Med Virol. 1995;47:172–178.[PubMed][Google Scholar]
117. Hudson JB, Zhou J, Chen J, Harris L, Yip L, Towers GHHypocrellin, from Hypocrella bambuase, is phototoxic to human immunodeficiency virus. Photochem. Photobiol. 1994;60:253–255.[PubMed][Google Scholar]
118. Lenard J, Rabson A, Vanderoef RPhotodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation. Proc. Natl. Acad. Sci. U. S. A. 1993;90:158–162.[Google Scholar]
119. Mohr H, Lambrecht B, Schmitt HPhoto-inactivation of viruses in therapeutical plasma. Dev. Biol. Stand. 1993;81:177–183.[PubMed][Google Scholar]
120. Sieber F, O’Brien JM, Gaffney DKMerocyanine-sensitized photoinactivation of enveloped viruses. Blood Cells. 1992;18:117–127.[PubMed][Google Scholar]
121. Carpenter S, Kraus GAPhotosensitization is required for inactivation of equine infectious anemia virus by hypericin. Photochem. Photobiol. 1991;53:169–174.[PubMed][Google Scholar]
122. Judy MM, Matthews JL, Newman JT, Skiles HL, Boriack RL, Sessler JL, Cyr M, Maiya BG, Nichol STIn vitro photodynamic inactivation of herpes simplex virus with sapphyrins: 22 pi-electron porphyrin-like macrocycles. Photochem. Photobiol. 1991;53:101–107.[PubMed][Google Scholar]
123. Neyndorff HC, Bartel DL, Tufaro F, Levy JGDevelopment of a model to demonstrate photosensitizer-mediated viral inactivation in blood. Transfusion. 1990;30:485–490.[PubMed][Google Scholar]
124. Chanh TC, Allan JS, Matthews JL, Sogandares-Bernal F, Judy MM, Skiles H, Leveson J, Marengo-Rowe A, Newman JTPhotodynamic inactivation of simian immunodeficiency virus. J. Virol. Methods. 1989;26:125–131.[PubMed][Google Scholar]
125. Matthews JL, Newman JT, Sogandares-Bernal F, Judy MM, Skiles H, Leveson JE, Marengo-Rowe AJ, Chanh TCPhotodynamic therapy of viral contaminants with potential for blood banking applications. Transfusion. 1988;28:81–83.[PubMed][Google Scholar]
126. Friedberg JS, Skema C, Baum ED, Burdick J, Vinogradov SA, Wilson DF, Horan AD, Nachamkin IIn vitro effects of photodynamic therapy on Aspergillus fumigatus. J. Antimicrob. Chemother. 2001;48:105–107.[PubMed][Google Scholar]
127. Carre V, Gaud O, Sylvain I, Bourdon O, Spiro M, Blais J, Granet R, Krausz P, Guilloton MFungicidal properties of meso-arylglycosylporphyrins: influence of sugar substituents on photoinduced damage in the yeast Saccharomyces cerevisiae. J. Photochem. Photobiol., B. 1999;48:57–62.[PubMed][Google Scholar]
128. Lazarova G, Tashiro HProtective effect of amphotericin B against lethal photodynamic treatment in yeast. Microbios. 1995;82:187–196.[PubMed][Google Scholar]
129. Paardekooper M, Van Gompel AE, Van Steveninck J, Van den Broek PJThe effect of photodynamic treatment of yeast with the sensitizer chloroaluminum phthalocyanine on various cellular parameters. Photochem. Photobiol. 1995;62:561–567.[PubMed][Google Scholar]
130. Sharma RK, Jain VEffects of 2-deoxy-D-glucose on the photosensitisation-induced bioenergetic changes in Saccharomyces cerevisiae as observed by in vivo NMR spectroscopy. Indian J. Biochem. Biophys. 1994;31:36–42.[PubMed][Google Scholar]
131. Lazarova GEffect of glutathione on rose bengal photosensitized yeast damage. Microbios. 1993;75:39–43.[PubMed][Google Scholar]
132. Bertoloni G, Rossi F, Valduga G, Jori G, Ali H, van Lier JEPhotosensitizing activity of water- and lipid-soluble phthalocyanines on prokaryotic and eukaryotic microbial cells. Microbios. 1992;71:33–46.[PubMed][Google Scholar]
133. Cohn GE, Tseng HYPhotodynamic inactivation of yeast sensitized by eosin Y. Photochem. Photobiol. 1977;26:465–474.[PubMed][Google Scholar]
134. Paardekooper M, Van den Broek PJ, De Bruijne AW, Elferink JG, Dubbelman TM, Van Steveninck JPhotodynamic treatment of yeast cells with the dye toluidine blue: all-or-none loss of plasma membrane barrier properties. Biochim. Biophys. Acta. 1992;1108:86–90.[PubMed][Google Scholar]
135. Grellier P, Santus R, Mouray E, Agmon V, Maziere JC, Rigomier D, Dagan A, Gatt S, Schrevel JPhotosensitized inactivation of Plasmodium falciparum- and Babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives. Vox Sang. 1997;72:211–220.[PubMed][Google Scholar]
136. Zhao XJ, Lustigman S, Li YS, Kenney ME, Ben-Hur EStructure-activity and mechanism studies on silicon phthalocyanines with Plasmodium falciparum in the dark and under red light. Photochem. Photobiol. 1997;66:282–287.[PubMed][Google Scholar]
137. Kliukiene R, Maroziene A, Cenas N, Becker K, Blanchard JSPhotoinactivation of trypanothione reductase and glutathione reductase by Al-phthalocyanine tetrasulfonate and hematoporphyrin. Biochem. Biophys. Res. Commun. 1996;218:629–632.[PubMed][Google Scholar]
138. Alouini Z, Jemli MDestruction of helminth eggs by photosensitized porphyrin. J. Environ. Monit. 2001;3:548–551.[PubMed][Google Scholar]
139. Millson CE, Wilson M, MacRobert AJ, Bown SGEx-vivo treatment of gastric Helicobacter infection by photodynamic therapy. J. Photochem. Photobiol., B. 1996;32:59–65.[PubMed][Google Scholar]
140. Sarkar S, Wilson MLethal photosensitization of bacteria in subgingival plaque from patients with chronic periodontitis. J. Periodont. Res. 1993;28:204–210.[PubMed][Google Scholar]
141. Wilson MBactericidal effect of laser light and its potential use in the treatment of plaque-related diseases. Int. Dent. J. 1994;44:181–189.[PubMed][Google Scholar]
142. Wood S, Nattress B, Kirkham J, Shore R, Brookes S, Griffiths J, Robinson CAn in vitro study of the use of photodynamic therapy for the treatment of natural oral plaque biofilms formed in vivo. J. Photochem. Photobiol., B. 1999;50:1–7.[PubMed][Google Scholar]
143. Lasocki K, Szpakowska M, Grzybowski J, Graczyk AExamination of antibacterial activity of the photoactivated arginine haematoporphyrin derivative. Pharmacol. Res. 1999;39:181–184.[PubMed][Google Scholar]
144. Berthiaume F, Reiken S, Toner M, Tompkins R, Yarmush MAntibody-targeted photolysis of bacteria in vivo. Biotechnology. 1994;12:703–706.[PubMed][Google Scholar]
145. Orenstein A, Klein D, Kopolovic J, Winkler E, Malik Z, Keller N, Nitzan YThe use of porphyrins for eradication of Staphylococcus aureus in burn wound infections. FEMS Immunol. Med. Microbiol. 1997;19:307–314.[PubMed][Google Scholar]
146. Teichert MC, Jones JW, Usacheva MN, Biel MATreatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg., Oral Med., Oral Pathol., Oral Radiol. Endod. 2002;93:155–160.[PubMed][Google Scholar]
147. Hamblin MR, O’Donnell DA, Murthy N, Contag CH, Hasan TRapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem. Photobiol. 2002;75:51–57.[PubMed][Google Scholar]
148. Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, Benaron DAPhotonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 1995;18:593–603.[PubMed][Google Scholar]
149. Benaron DA, Contag PR, Contag CHImaging brain structure and function, infection and gene expression in the body using light. Philos. Trans. R. Soc. London, Ser. B. 1997;352:755–761.[Google Scholar]
150. Zhang W, Contag PR, Madan A, Stevenson DK, Contag CHBioluminescence for biological sensing in living mammals. Adv. Exp. Med. Biol. 1999;471:775–784.[PubMed][Google Scholar]
151. Hamblin MR, Zahra T, Contag CH, McManus AT, Hasan TOptical monitoring and treatment of potentially lethal wound infections in vivo. J. Infect. Dis. 2003;187:1717–1725.[Google Scholar]
152. Roome AP, Tinkler AE, Hilton AL, Montefiore DG, Waller DNeutral red with photoinactivation in the treatment of herpes genitalis. Br. J. Vener. Dis. 1975;51:130–133.[Google Scholar]
153. Melnick JL, Rawls WEPhotoinactivation of herpes simplex virus continues to look promising. JAMA, J. Am. Med. Assoc. 1973;226:79–80.[PubMed][Google Scholar]
154. Bockstahler LE, Lytle CD, Hellman KBA review of photodynamic therapy for herpes simplex: benefits and potential risks. N. Y. J. Dent. 1975;45:148–157.[PubMed][Google Scholar]
155. Myers MG, Oxman MN, Clark JE, Arndt KAFailure of neutral-red photodynamic inactivation in recurrent herpes simplex virus infections. N. Engl. J. Med. 1975;293:945–949.[PubMed][Google Scholar]
156. Chang TWViral photoinactivation and oncogenesis. Arch. Dermatol. 1976;112:1176.[PubMed][Google Scholar]
157. Shikowitz MJ, Abramson AL, Freeman K, Steinberg BM, Nouri MEfficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results. Laryngoscope. 1998;108:962–967.[PubMed][Google Scholar]
158. Abramson AL, Shikowitz MJ, Mullooly VM, Steinberg BM, Amella CA, Rothstein HRClinical effects of photodynamic therapy on recurrent laryngeal papillomas. Arch. Otolaryngol. Head Neck Surg. 1992;118:25–29.[PubMed][Google Scholar]
159. Bujia J, Feyh J, Kastenbauer E. Photodynamic therapy with derivatives from hemotoporphyrines for recurrent laryngeal papillomatosis of the children. Early results. An. Otorrinolaringol. Ibero Am. 1993;20:251–259.[PubMed]
160. Karrer S, Szeimies RM, Abels C, Wlotzke U, Stolz W, Landthaler MEpidermodysplasia verruciformis treated using topical 5-aminolaevulinic acid photodynamic therapy. Br. J. Dermatol. 1999;140:935–938.[PubMed][Google Scholar]
161. Abdel-Hady ES, Martin-Hirsch P, Duggan-Keen M, Stern PL, Moore JV, Corbitt G, Kitchener HC, Hampson INImmunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res. 2001;61:192–196.[PubMed][Google Scholar]
162. Lombard GF, Tealdi S, Lanotte MM. The treatment of neurosurgical infections by lasers and porphyrins. In: Jori G, Perria CA, editors. Photodynamic Therapy of Tumors and other Diseases. Padova: Edizione Libreria Progetto; 1985. pp. 363–366. [PubMed]
163. Hjalmarsson S, Sjolund M, Engstrand LDetermining antibiotic resistance in Helicobacter pylori. Expert Rev. Mol. Diagn. 2002;2:267–272.[PubMed][Google Scholar]
164. Xia HH, Yu Wong BC, Talley NJ, Lam SKAlternative and rescue treatment regimens for Helicobacter pylori eradication. Expert Opin. Pharmacother. 2002;3:1301–1311.[PubMed][Google Scholar]
165. Wilder-Smith CH, Wilder-Smith P, Grosjean P, Van Den Bergh H, Woodtli A, Monnier P, Dorta G, Meister F, Wagnieres GPhotoeradication of Helicobacter pylori using 5-aminolevulinic acid: preliminary human studies. Lasers Surg. Med. 2002;31:18–22.[PubMed][Google Scholar]
166. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RRTopical ALA-photodynamic therapy for the treatment of acne vulgaris. J. Invest. Dermatol. 2000;115:183–192.[PubMed][Google Scholar]
167. Itoh Y, Ninomiya Y, Tajima S, Ishibashi APhotodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid. Arch. Dermatol. 2000;136:1093–1095.[PubMed][Google Scholar]
168. Itoh Y, Ninomiya Y, Tajima S, Ishibashi APhotodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients. Br. J. Dermatol. 2001;144:575–579.[PubMed][Google Scholar]
169. Dunn BE, Cohen H, Blaser MJHelicobacter pylori. Clin. Microbiol. Rev. 1997;10:720–741.[Google Scholar]